Manning, Anthony M.
Momenta Pharmaceuticals (United States)
3 papers on CoChatORCID 0000-0002-7743-5489
Most cited papers
- Verified
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences
Protein Kinase Regulation and GTPase SignalingNF-κB Signaling Pathways
Cited by 2,558
- Verified
Targeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 585
- Verified
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences
Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research
Cited by 225
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free